Written by Karen Pilkington and the CAM-Cancer Consortium.
Updated June 25, 2017

Ozone therapy

Does it work?

Systematic reviews, meta-analyses

No systematic reviews of ozone therapy in relation to cancer have been published. Systematic reviews have been published on other uses, for example, in the field of dentistry and in herniated discs19,20.

Clinical trials

No randomised controlled trials have been conducted to assess the effects of ozone therapy in cancer patients.

An open uncontrolled study of ozone therapy in chemotherapy-resistant cancer patients was initiated in 200318. Preliminary findings revealed that, in patients with a Karnofsky performance score of less than 40% (on a scale of 0 to 100% where 0 represents death and 100% reflects normal activity/function and no evidence of disease), no effect on disease progression was observed. Patients with a Karnofsky score of 70% or less reported an improvement in quality of life after 30-45 treatments. The lack of a control group and subjective nature of the outcome measure prevent definitive conclusions being reached, a point conceded by the researcher.

Results of a pilot, uncontrolled study of ozone therapy for tumour oxygenation were published in 200422. Eighteen patients with metastases or advanced tumours accessible to physical examination were enrolled in the study. All patients had a Karnofsky performance status of > 70%, 15 were male and 14 had head and neck tumours, 2 had gynaecological tumours and 2 had bone metastases in the chest wall. Ozone autohaemotransfusion was administered on 3 alternate days in one week. Tumour oxygenation levels were measured using needle probes. No overall statistically significant change was observed. No adverse effects were recorded. Due to the small sample size and uncontrolled nature of the study, these can only be considered preliminary findings. In addition, the clinical relevance of the observed changes in tumour oxygenation is not entirely clear although tumour hypoxia has been reported to adversely affect prognosis in tumours such as those of the head and neck tumours23,24.

A further controlled study by this research group from Spain focused specifically on patients with advanced head and neck tumours who were undergoing radiotherapy25. Nineteen patients were recruited and studied over a 3 year period. Twelve patients received chemotherapy in addition to radiotherapy while 7 received ozone therapy plus radiotherapy. The two groups were not well-matched as the ozone therapy group was older with greater lymph node involvement. However, no significant difference in overall survival was recorded between the two groups.

Ozone has been investigated for other uses in cancer patients. These include a single case report described intravesical instillation of ozonized water in a patient with progressive radiation-induced haematuria26. Osteonecrosis of the jaw has also been reportedly managed with treatments including ozone in myeloma patients (n=1227 and n=127) as well as a separate series of 10 patients with bone metastases28. Preliminary findings on the effects of ozone by rectal insufflations and/or by local application of ozonized-oil, in small uncontrolled studies in patients (19,17 and 12 respectively) with severe and/or refractory radiation-induced haemorrhagic proctitis or bleeding29,37,38. To date, none of these preliminary findings have been confirmed with randomised controlled trials.

Citation

Karen Pilkington, CAM-Cancer Consortium. Ozone therapy [online document]. http://www.cam-cancer.org/The-Summaries/Other-CAM/Ozone-therapy. June 25, 2017.

Document history

Fully updated and revised in June 2017 by Karen Pilkington.
Updated/assessed as up to date by Barbara Wider in September 2013.
Summary first published in October 2012, authored by Karen Pilkington.

References

  1. Elvis AM. Ekta JS. (2011) Ozone therapy: A clinical review. Journal of Natural Science Biology & Medicine. 2(1):66-70.
  2. Bocci V.A.(2006) Scientific and Medical Aspects of Ozone Therapy. State of the Art. Archives of Medical Research. 37 (4) (pp 425-435).
  3. United States Environmental Protection Agency.(2012). Ground Level Ozone Basic Information. Available at: https://www.epa.gov/ozone-pollution. Accessed 11th April 2017.
  4. Natural Medicines Database: professional version. Ozone therapy monograph. Somerville (MA): Therapeutic Research Faculty. Accessed 11th April 2017.
  5. Cassileth B. (2009) Oxygen therapies. Oncology (Williston Park). 23(13):1182.
  6. Burke FJ.(2012). Ozone and caries: a review of the literature. Dent Update. 39(4):271-2, 275-8.
  7. European Cooperation of Medical Ozone Societies EUROCOOP. Accessed 11th April 2017.
  8. German Medical Society for the Use of Ozone in Prevention and Therapy. (Ärztliche Gesellschaft für Ozon-Anwendung in Prävention und Therapie). Guidelines. Accessed 11th April 2017
  9. Rubin MB. (2001). The History Of Ozone. The Schönbein Period, 1839-1868. Bull. Hist. Chem., 26 (1). Accessed 11th April 2017.
  10. Bocci V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci. 1999;56(4):270-9.
  11. Sagai M., Bocci V. (2011). Med Gas Res. 2011 Dec 20;1:29. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress? Medical Gas Research. 1 (1). Article Number: 29.
  12. Bocci V., Larini A., Micheli V. (2005). Restoration of normoxia by ozone therapy may control neoplastic growth: A review and a working hypothesis. Journal of Alternative and Complementary Medicine. 11 (2): pp 257-265.
  13. Höckel M, Vaupel P.(2001). Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 93(4):266-76.
  14. Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R, Ernst E. (2010). Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract. 64(11):1496-502. doi: 10.1111/j.1742-1241.2010.02484.x.
  15. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N, Patiraki E. (2005). Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 16(4):655-63. Epub 2005 Feb 2.
  16. Molassiotis A., Ozden G., Platin N., Scott J.A., Pud D., Fernandez-Ortega P., Milovics L.,Panteli V., Gudmundsdottir G., Browall M., Madsen E., Patiraki E. & Kearney N. (2006). Complementary and alternative medicine use in patients with head and neck cancers in Europe. European Journal of Cancer Care 15: 19–24.
  17. Jacobson JS, Grann VR, Gnatt MA, Hibshoosh H, Austin JH, Millar WS, Neugut AI. (2005). Cancer outcomes at the Hufeland (complementary/alternative medicine) klinik: a best-case series review. Integr Cancer Ther. 4(2):156-67.
  18. United States Food and Drug Administration. (2017). Title 21--Food And Drugs.Chapter I--Food And Drug Administration Department Of Health And Human Services. Subchapter H--Medical Devices. Accessed 11th April 2017.
  19. Magalhaes FN, Dotta L, Sasse A, Teixera MJ, Fonoff ET. Ozone therapy as a treatment for low back pain secondary to herniated disc: a systematic review and meta-analysis of randomized controlled trials. Pain Physician. 2012 Mar-Apr;15(2):E115-29.
  20. Rickard GD, Richardson R, Johnson T, McColl D, Hooper L. Ozone therapy for the treatment of dental caries. Cochrane Database Syst Rev. 2004;(3):CD004153.
  21. Re L, Mawsouf MN, Menéndez S, León OS, Sánchez GM, Hernández F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008 Jan;39(1):17-26. Epub 2007 Sep 29.
  22. Clavo B, Pérez JL, López L, Suárez G, Lloret M, Rodríguez V, Macías D, Santana M, Hernández MA, Martín-Oliva R, Robaina F. Ozone Therapy for Tumor Oxygenation: a Pilot Study. Evid Based Complement Alternat Med. 2004 Jun 1;1(1):93-98.
  23. Janssen HL, Haustermans KM, Balm AJ, Begg AC. Hypoxia in head and neck cancer: how much, how important? Head Neck. 2005 Jul;27(7):622-38.
  24. Buffa FM, Harris AL, West CM, Miller CJ. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer. 2010 Jan 19;102(2):428-35. Erratum in: Br J Cancer. 2010 Sep 7;103(6):929.
  25. Clavo B, Ruiz A, Lloret M, López L, Suárez G, Macías D, Rodríguez V, Hernández MA, Martín-Oliva R, Quintero S, Cuyás JM, Robaina F. Adjuvant Ozonetherapy in Advanced Head and Neck Tumors: A Comparative Study. Evid Based Complement Alternat Med. 2004 Dec;1(3):321-325. Epub 2004 Oct 16.
  26. Clavo B, Gutierrez D, Martin D, Suarez G, Hernandez MA, Robaina F. (2005). Intravesical ozone therapy for progressive radiation-induced hematuria. J Altern Complement Med 11(3):539-541.
  27. Petrucci MT, Gallucci C, Agrillo A, Mustazza MC, Foa R. (2007). Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 92(9):1289-1290.
  28. Ripamonti CI, Cislaghi E, Mariani L, Maniezzo M. (2011). Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study. Oral Oncol 47(3):185-190.
  29. Clavo B, Ceballos D, Gutierrez D, Rovira G, Suarez G, Lopez L, Pinar B, Cabezon A, Morales V, Oliva E, Fiuza MD, Santana-Rodriguez M. Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy.J Pain Symptom Manage. 2013 Jul;46(1):106-12.
  30. Schulz S, Haussler U, Mandic R, Heverhagen JT, Neubauer A, Dunne AA et al. Treatment with ozone/oxygen-pneumoperitoneum results in complete remission of rabbit squamous cell carcinomas. Int J Cancer 2008; 122(10):2360-2367.
  31. Kesik V., Uysal B., Kurt B., Kismet E., Koseoglu V. Ozone ameliorates methotrexate-induced intestinal injury in rats. Cancer Biology and Therapy. 2009; 8 (17):1623-1628.
  32. Sweet F, Kao MS, Lee SC, Hagar WL, Sweet WE. Ozone selectively inhibits growth of human cancer cells. Science 1980; 209(4459):931-933.
  33. Bocci V, Luzzi E, Corradeschi F, Silvestri S. Studies on the biological effects of ozone: 6. Production of transforming growth factor 1 by human blood after ozone treatment. J Biol Regul Homeost Agents 1994; 8(4):108-112.
  34. Zanker KS, Kroczek R. In vitro synergistic activity of 5-fluorouracil with low-dose ozone against a chemoresistant tumor cell line and fresh human tumor cells. Chemotherapy 1990; 36(2):147-154.
  35. Jerrett M, Burnett RT, Pope CA 3rd, Ito K, Thurston G, Krewski D, Shi Y, Calle E, Thun M. Long-term ozone exposure and mortality. N Engl J Med. 2009 Mar 12;360(11):1085-95.
  36. Faustini A, Capobianchi MR, Martinelli M, Abbate I, Cappiello G, Perucci CA. A cluster of hepatitis C virus infections associated with ozone-enriched transfusion of autologous blood in Rome, Italy. Infect Control Hosp Epidemiol. 2005 Sep;26(9):762-7.
  37. Yoo C, Kang CS, Choi YL, Kang HY, Kim JM, Koh YH, et al. Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy. Korean J Pathol. 2012;46(5):436-42.
  38. Clavo B, Santana-Rodriguez N, Llontop P, Gutierrez D, Ceballos D, Mendez C, et al. Ozone Therapy in the Management of Persistent Radiation-Induced Rectal Bleeding in Prostate Cancer Patients. Evidence-based complementary and alternative medicine: eCAM. 2015;2015:480369.
  39. Luongo M, Brigida AL, Mascolo L, Gaudino G. Possible Therapeutic Effects of Ozone Mixture on Hypoxia in Tumor Development. Anticancer Res. 2017 Feb;37(2):425-435.